Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Cancer Health Center

Font Size

Rat Study Shows Cancer, Aspartame Link

But Critics Charge That Research Is Flawed
WebMD Health News

Nov. 18, 2005 - A study in rats links the popular artificial sweetener aspartame to a wide range of cancers, but industry officials charge that the research is badly flawed.

Aspartame is found in the low-calorie sweetener Equal and in many other sugar-free products under the brand name NutraSweet. It is the second best-selling nonsugar sweetener in the world.

Researchers in Italy concluded that rats exposed to varying doses of aspartame throughout their lives developed leukemias, lymphomas, and several other cancers in a dose-dependent manner.

They report that the product is a potential cancer-causing agent to humans even at levels that are less than half of what is considered safe by the U.S. government.

Critics Respond

The study appears in the Nov. 17 issue of the journal Environmental Health Perspectives, which is published by the National Institute of Environmental Health Sciences (NIEHS) of the U.S. Department of Health and Human Services.

But critics charged that the investigators did not follow the guidelines for scientific study outlined by the NIEHS' own research group, the National Toxicology Program. They further noted that the NTP's own animal studies involving similar levels of aspartame exposure showed no link between the sweetener and an increase in cancers.

And an NIEHS spokesperson said Friday that the agency had "no role in the design, performance, or interpretation" of the newly published study.

'Findings Speak for Themselves'

The study was conducted by researchers from the European Ramazzini Foundation, an independent group located in Bologna, Italy.

One hundred male rats and 100 female rats were followed from 8 weeks of age until their deaths from natural causes. The rats were fed aspartame at doses approximating a wide range of human consumption levels, from very low levels to very high.

Each rat was autopsied following its spontaneous death, and exposed animals were found to have a higher rate of leukemias, lymphomas, kidney and pelvic cancers and a brain cancer.

Researcher Morando Soffritti, MD, and colleagues called for an "urgent re-evaluation" of the current guidelines for the use of aspartame.

"The findings speak for themselves," he tells WebMD. "They show the potential carcinogenicity of aspartame in animals."

Today on WebMD

Colorectal cancer cells
New! I AM Not Cancer Facebook Group
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Real Cancer Perspectives
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas